Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telavancin CNS Penetration in SAH Patients With EVDs
NCT06119061Phase 4Recruiting
- Start
- Jul 2024
- Primary completion
- Dec 2026
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of telavancin in bacterial meningitis, ventriculitis. Started Jul 2024; status: recruiting.
02
Drugs
telavancin
03
Conditions
bacterial meningitisventriculitis
Beyond the preview
Go deeper on NCT06119061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06119061.